Hexcel Corporation reports Q2 results on July 30 with the stock already under pressure — down 4% on the session to $105.61 — even as the broader short-selling community has been quietly stepping back from the name.
The short interest story has shifted meaningfully in recent weeks. Bears have been covering, not piling in: short interest dropped nearly 10% over the past week to 4.6% of the free float, and is down 17% from a month ago. Borrow availability remains extremely loose at 508%, meaning roughly five shares are available to lend for every one already borrowed — no squeeze pressure, no crowding. Cost to borrow is a negligible 0.57%. The ORTEX short score has also eased, falling from 48.7 a week ago to 45.4, reinforcing the picture of retreating rather than escalating bearish conviction. Options traders are equally relaxed: the put/call ratio is 0.28, barely a standard deviation above its 20-day average, and nowhere near levels that would signal defensive hedging into the print.
The bull and bear cases heading into today's release are sharply drawn. Bulls point to a projected roughly 50% jump in working business revenues over 2026–2028, a free cash flow run-rate of around $96.5 million — up 32% year-on-year and well above consensus — and the Defence, Space and Other segment growing 13% year-on-year to $182 million. The stock is up nearly 50% year-to-date, driven by those tailwinds. Bears counter with compressed margins — gross margins down to 21.9%, adjusted operating margins slipping to 9.8% — and guidance that was revised lower to reflect tariff headwinds and inventory destocking. Full-year revenue growth is expected at only around 8% at the midpoint. The analyst community reflects that tension: recent target raises from TD Cowen (to $100) and Jefferies (to $105) both kept Hold ratings, and the consensus mean target of $99.79 now sits below the current price of $105.61, suggesting the Street collectively sees the stock as running ahead of fundamentals. The valuation is not cheap — trailing PE near 39x and EV/EBITDA above 20x.
One data point that has not changed since yesterday's note is the CEO's insider activity. Nick Stanage sold over $11.6 million in stock across two transactions on July 14 and July 23, with no open-market purchases to offset. That pattern remains the most discussed signal around the stock heading into the print. Peers offer mixed context: HWM and GE both gained on the week, while ATI and CRS fell roughly 5% — suggesting some sector-level softness that HXL has not been immune to, particularly on today's session.
The Q2 print is therefore a test of whether the underlying revenue and margin trajectory can justify a valuation that has moved well past the consensus target, against a backdrop of an executive who has been a significant net seller at these levels.
See the live data behind this article on ORTEX.
Open HXL on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
